FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$2.45
Tradestie Score
50
Market Cap
$144.16M
Revenue Growth
-0.2%
Analyst Upside
+120.9%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.49
|
$308.74M | - | 54 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.01
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$19.75
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$28.03
|
$293.03M | - | 51 | Compare |
|
OMER
Omeros Corporation
|
$11.84
|
$281.75M | 10.2 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.50
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.88
|
$275.13M | - | 50 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$21.15
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.43
|
$262.67M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
More FATE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry